Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
EPS Over TimeContracting
Percentile Rank40
Studio
Year-over-Year Change

Earnings per share

Latest
-2.02
↓ 22% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-1.66
Historical baseline
PeriodValueYoY Change
2025-2.02+3.8%
2024-2.10+23.4%
2023-2.74-93.0%
2022-1.42-12.7%
2021-1.26-207.3%
2020-0.41-